Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Filings by Wellington Biomedical Innovation Master Investors (Cayman) I L.P. span 6 companies, the busiest being Acrivon Therapeutics, Inc., Artiva Biotherapeutics, Inc. and Boundless Bio, Inc. We count 6 filings; the first trade dates from 21 June 2021 and the latest from 16 September 2024.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 18 September 2024: a transaction, in Zenas BioPharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.